Member Info for dactions

I meant to say approx 50 reviews in the last 24 hours.

This is a typical review where presumably Royal Mail is failing (although the reviewer still gave 5 stars).
"Royal Mail delivery was slow. I posted my completed sample at around 11:30 am on Wednesday 8th December. It was delivered to MyHealthChecked at 07:24 on Friday 10th December. I thought that it would have been delivered the next day as it was posted in a Priority post box as directed and tracked. MyHealthChecked processed the test and emailed the result to me at 13:34, within 6 hours of receipt of the sample which was very good."

"I'm remaining very positive here"

@llywelyn - I don't disagree with you - outlook looking very good really.

Just had a look on TrustPilot and there are approx 50 reviews in the 24 hours - just about all of them were 5 stars - a few 4 stars.

4 though reported Royal Mail delays despite all saying they mailed in the Priority Mailbox. In 3 of those cases MHC still performed the tests in time but of course didn't get the 'brownie points' they deserved. One said the kit didn't work !

I talked myself into a small top-up too at 4.2p

I felt the recent falls were more about the MMs trying to stimulate business - as there's been relatively little selling these past weeks. To my mind, today's price is still undervaluing the stock and should be a good opportunity for new buyers or top-ups. We know their business figures right up to the 3rd quarter have been excellent so I can't see why the current quarter should be any different.

jamrock - not me that said anything about LFT testing but I do maintain it is unrealistic to expect any announcement this side of January from the management.

Palmsairport - I heard from someone close to the company, that they are working very hard on continuing Covid testing and also that they rated Penny very highly. My comments perhaps don't sound that special but it made me sit up when I heard them. All the best.

Why don't you report it to the moderators ? If we all did it they'll be removed.

"Time for the board to speak"

That's not going to happen Jamrock - you can't expect hand-holding on share movements especially this close to year-end . Once we're into January there will be a case but not now. By the way, I have it on good authority that they are continuing to work intensely on tests.

OK - I guess you're right @bucolic - [Filtered]

I've already filtered:
@liambooth
@ssl1975

This share board has been totally spoiled in any case . But despite all this nonsense from you all, as a long-term holder going back 9 years, it doesn't stop me considering FUM as an excellent share and one that will soon have it's day in my opinion.

GLA to the real investors in FUM.

With all due respect to you guys, it's become rather juvenile on this board.

@bucolic - on 18.10.21 you said "Filter and ignore - it's the only way to avoid the fate of the ADVFN FUM board" - all you ever post is a counter argument to @liambooth.
@the.italian - it's just a continuous discussion between you three.

I can only assume all of you must be one and the same disrupter - I've never experienced such silliness from supposedly mature adults - weird ?!?

I am afraid this is the kind of civil service ineptitude we have become used to in the UK. You see it in all aspects of life in Britain today. As for the ranking, it is primarily based on price the last time I looked so firms offering tests at 40p were shown first.

The whole system is farcical and to think we pay them to produce this nonsense.

roly12 - to have come through a year moulding the business to grab the Covid opportunity - from a disaster women's fertility product (which on the face of it should have scored big time), shows excellent business acumen from a small team. The thousands and thousands of pcr tests they've processed and end the year with such a realistically brilliant TrustPilot score, shows excellent efficiency too.

We've been told along the way, how cash flow positive they are and now profit generative - although we can only guess at numbers right now. I'm hoping we will have an early indication just how profitable early in the new Year.

I don't think we've been given any pricing indications of the dna test kits but their link to Boots and Lloyds Pharmacy means presumably they'll want to service the products primarily via them. There's a US company, multi million sales which I wonder if MHC has based it's own business model on - letsgetchecked.com. They appear a very successful company offering a very wide range of tests - eg coeliac test at £59 and fertility tests from £69 - £119. To me, MHC has every possibility of doing well with the Boots/ Lloyds connection in competition with letsgetchecked.com. It clearly is a massive market and MHC has shown it can handle the business pressure.

So, in summary, the outlook looks good for us in the near and long term. The shares offer the potential of a multi-bagger from these levels and I don't think the market has yet understood the Company's potential. We'll be in a better position to understand, once the end year results are announced.

"In addition to the physical symptoms it also places a psychological weight on your shoulders - the fear that tomorrow you might be one of the few who end up in hospital"

Your post is very profound and to learn of the mental anguish too is a good reminder, if ever needed, of the impact this disease is having. Good luck on your recovery and in my rusty Italian "Spero che ti sentirai meglio presto"

Roly12 - you say yesterday's fall strange, on no news or selling pressure but the latter happened in a very big way yesterday. You only have to look at all the delayed deals which were in themselves individually sizable and shown as non-classified - but they were undoubtedly Sells. The share had been ramped hard by some on here - goodness knows what it was like on ADVFN.

However, I fully agree with your insight that MHC are trying to establish there own brand and I couldn't agree with you more that , if successful the SP will be in the high teens. You say 2 years and I guess that is realistic but it could as easily happen a lot sooner dependent whether we're all still doing Covid-19 or whether MHC is focusing instead on the new products.

jamrock - you and BFFM are not related are you ??

You two remind me of Brothers always quarreling - as I can't see it, I assume it's from Brother Booth :-)

Thank goodness Lombard Odier have their sights focussed - roll on upwards FUM.

Really good news to see Lombard Odier is still increasing its holding. Was only a few months back that it was around 22% and then in September 24% and now today we learn they have 25%.

I added to my own holding at 34p a few days back as I had a hunch we might get the news we're waiting for from FUM. The news being, of course, what's happening with the European and UK markets. I'm still confident that we'll see progress on this front soon. Having seen an advert recently for ED suggesting electric shock treatment in a local magazine, Eroxon should corner the market surely.

GLA

You have a cheek littering a decent bulletin board with your multitude of threads - how many newbies did you suck in just so you could offload !
[Filtered]

FortKnight - thanks for the link.

That must be a first for MHC - very enterprising - and hopefully they'll offer it more widely through the educational sector.

fandango123 - [Filtered]

Out of nowhere this MHC board has been flooded with multi threads from Rampers who are solely trying to manipulate our investment decisions. It doesn't take much guesswork to recognise who they are.

Best to [Filter] them.